Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > What are the Listing requirements for the NASDAQ?

<< Previous

Bullboard Posts

Next >>

Comment by silentrunningon Jan 10, 2021 2:16pm

87 Views

Post# 32263587

RE:RE:RE:RE:RE:RE:What are the Listing requirements for the NASDAQ?

Great DD ! Cheers Didn't think it was an impossible scenario, certainly not my intent to distract from upcoming news or 2nd guess mgmt. Best

bligicka wrote: Yes Info your absolutely right, thanks for pointing that out..... I guess we need a $5 Canadian Share Price then .......lets get there !!!!

Inforaswing14 wrote: Hopefully you do more research on Nasdaq listing requirements. You only need to fulfill 1 of 4 requirements